Evaluation of clinical outcome, treatment compliance and tolerability of adalimumab in patients with active rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis in Hungary: results from EviraEast, a multi-country, multi-center post marketing observational study

Poór, GyulaGéher, PálDrescher, EditJuhász, PéterKeszthelyi, PéterKovács, LászlóNagy, OrsolyaRojkovich, BernadetteRuzicska, ÉvaSchnaider, TamásSzántó, SándorSütő, GáborVarga, Eszter2018-05-152018-05-152014Magyar Reumatológia. -55 (2014), p. 12-24. -Magyar Reumatol. - 0139-44950139-4495http://hdl.handle.net/2437/252203Evaluation of clinical outcome, treatment compliance and tolerability of adalimumab in patients with active rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis in Hungary: results from EviraEast, a multi-country, multi-center post marketing observational studyfolyóiratcikkopen access journalhttp://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM073682OrvostudományokKlinikai orvostudományokMRE2018-11-23